Get In Touch

Tourette syndrome is a neuropsychiatric disorder, characterized by physical and vocal tics. Tics are repetitive and non-rhythmic movements of discrete muscle group and are formed due to genetic mutation that disrupt the production of histamine in the brain. Tourette syndrome is primarily caused due to the disturbance in the balance of neurotransmitter in the brain, which carries nerve signals from cell to cell. This syndrome is associated with the exclamation of obscene words or socially inappropriate remarks. Tourette syndrome is a genetic disorder that affects children and teenagers. Tourette syndrome also increases the risk of hyperactivity disorder or obsessive-compulsive disorder in children. Blinking, frowning, jerking, and foot stamping are some of the symptoms of Tourette syndrome. Drugs that target histamine receptors are helpful in treating this disorder. Currently, no single drug has been approved for the treatment of tourette syndrome; however, the current treatments help manage tics or other related symptoms caused by the syndrome. Based on treatment, the Tourette syndrome market is segmented into medication and therapy. Medication includes dopamine antagonists, botulinum injections, central adrenergic inhibitors, antidepressants, and anticonvulsant agents. Therapy includes behavior therapy, psychotherapy, and deep brain stimulation.

The global Tourette syndrome market is expanding at a rapid pace due to consistent efforts of several organizations to increase awareness regarding the disease among patients. For example, the Center for Disease Control and Prevention (CDC) is engaged in improving the understanding about Tourette syndrome among people. This organization is actively working to identify causes of the syndrome to help patients effective manage of this syndrome. Additionally, the organization is also conducting education programs to improve the quality of life for Tourette syndrome patients. Risk of Tourette syndrome in children is more as compared to adult and geriatric population. For example, in a study conducted in 2012 by the Centre for Disease Control and Prevention stated that approximately 1 out of 360 children (about 138,000 children) were diagnosed with Tourette syndrome in the year 2011. Therefore, increase in incidence rate of Tourette syndrome is expected to the Tourette syndrome market in future. Moreover, large number of ongoing clinical trials are estimated to further boost the market. For example, Ecopipam, a drug by Psyadon Pharmaceuticals, is currently in phase-2 for the treatment of Tourette syndrome. Other drugs in pipeline include Seridopidine, SNC-102, and ABX1431. This drug has shown favorable safety profile for the treatment of Tourette syndrome. Thus, increase in research & development expenditure and activities and entry of new therapeutics into the market, is anticipated to boost the tourette syndrome market in the forecast period. However, high cost of therapy and side effects associated to these drugs are likely to hamper the market.

In terms of geography, the global Tourette syndrome market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global Tourette syndrome market due to the presence of a larger number of key players such as Catalyst Pharmaceutical Partners, Inc., AstraZeneca PLC, and Otsuka Holdings Co., Ltd in the region. Europe is the second largest Tourette syndrome market. The Tourette syndrome market is expanding in Europe owing to its high incidence rate. Furthermore, the Tourette syndrome market in Asia Pacific is expanding due to increasing awareness regarding Tourette syndrome among patients.

Key players operating in the global Tourette syndrome market include Edison Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Catalyst Pharmaceutical Partners, Inc., AstraZeneca PLC, Reviva Pharmaceuticals Inc., Psyadon Pharmaceuticals, Inc., and Auspex Pharmaceuticals, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Tourette Syndrome Market

Pre Book